Compare Cytokinetics Inc (CYTK) vs Dow Jones Industrial Average ETF (DIA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Dow Jones Industrial Average ETF — how do they compare? Cytokinetics Inc trades at $62.91 (market cap $8.62B), while Dow Jones Industrial Average ETF trades at $516.07 (market cap $45.20B). The key difference: Dow Jones Industrial Average ETF is far larger — about 5.2× Cytokinetics Inc's market cap, and Dow Jones Industrial Average ETF is trading nearer its 52-week high, Cytokinetics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cytokinetics Inc for 19 Days and Dow Jones Industrial Average ETF for 104 Days on average.
| CYTK | DIA | |
|---|---|---|
Market Cap | $8.62B | $45.20B |
Volume | 2,594,626 | 4,095,368 |
Sector | Health | — |
52-Week High | $87.26 | $542.79 |
52-Week Low | $54.76 | $451.37 |
Typical Hold Time | 19 Days | 104 Days |
Enterprise Value | $8.72B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CYTK trades at $62.01, up 1.46% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported Q2 2026 EPS of -$1.50, beating expectations, but maintains deeply negative profitability with a net income margin of -1,321.12% for 2026. Recent news highlights clinical progress for aficamten in hypertrophic cardiomyopathy studies and presentations at major medical conferences.
Wall Street sentiment is overwhelmingly bullish with a 97.14% buy rating and a $112.60 consensus price target, signaling strong upside potential. However, high cash burn, substantial losses, and significant debt-to-asset ratio of 81.23% present substantial financial risks. Investment appeal hinges on successful commercialization of its pipeline amid intense competition.
DIA (SPDR Dow Jones Industrial Average ETF Trust) trades at $511.65 with minimal daily movement (+0.12%). Technical indicators show a bearish bias with moving averages signaling sell pressure, though oscillators remain neutral. The ETF maintains a dividend distribution schedule with recent payouts ranging from $0.15 to $1.19. Market breadth indicators suggest broader market weakness, creating headwinds for this Dow-tracking fund.
The outlook remains cautious given the bearish technical setup and negative market sentiment. Dividend income provides some stability, but the fund faces pressure from declining market breadth and elevated bond yields. Key resistance at $513-516 levels must be breached for bullish momentum to develop.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Dow Jones Industrial Average ETF
The ETF is designed to track the performance of the securities and the stocks in the Dow Jones Industrial Average Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on DIA →
